Pathogenic microorganisms overcome the host's innate and adaptive immune system and cause local or systemic infections, potentially leading to organ failure, sepsis, or even death. Some microorganisms can also directly or indirectly alter the differentiation and proliferation of host cells, promoting the development of tumors. A large number of oncogenic viruses have been identified and estimated to account for~15% of human cancers. They do so by encoding oncogenes or through their intrinsic ability to manipulate the genomic stability of the host cell by integrating their own genetic elements. Also bacterial infections have been linked to carcinogenesis, although the underlying molecular mechanisms are less well understood. The beststudied example is Helicobacter pylori, which has been classified as a class I carcinogen by the World Health Organization due to its ability to promote stomach cancer after chronic infection, which causes tissue inflammation and atrophy of the gastric mucosa. In a recent issue of Cell Host & Microbe, the Neefjes laboratory explores the association between Salmonella enterica subsp. enterica sv. Typhi (S. Typhi)-which is the causative agent of human typhoid fever-and gallbladder carcinoma [1] .
See also: T Scanu et al C hronic carriage of S. Typhi following acute infection has been previously linked to cancer [2] . Although gallbladder carcinoma (GBC) is rare in western countries, there is a high incidence in countries with endemic S. Typhi infections such as South America and parts of Africa and Asia, particularly India and Pakistan [3, 4] . Salmonella's ability to persist within the gallbladder of a significant fraction of patients (2-5%) after systemic infection appears to provide the milieu for its tumor-promoting effect. Initial experimental evidence in mice supports an association between Salmonella infection and GBC, as long-term histopathological follow-up of chronically infected mice revealed pre-malignant lesions with hyperplasia and metaplasia of the gallbladder [5] . Now, Scanu and colleagues provide insights into the molecular mechanisms underlying this association [1] .
They start with the intriguing observation that GBC in the Netherlands, which has a very low incidence of S. Typhi infection, differs phenotypically from GBC in India, where the incidence of typhoid fever is very high. Furthermore, the authors detect increased expression of the proto-oncogene c-Myc in Indian tumor tissue and set out to test the effect of Salmonella infection in tumor-prone mice that express enhanced c-Myc levels, the so-called adenomatous polyposis coli (Apc) +/min mouse model. (Fig 1) . The established models now provide unique tools to further unravel the molecular mechanisms of bacteria-induced carcinogenesis. Similar to the clinical management of H. pylori, the results call for the development of strategies to prevent S. Typhi persistence in the attempt to not only stop the spread of this pathogen, but also prevent the development of GBC, a disease with poor clinical outcome at present. However, a number of questions remain to be addressed. For example, the authors assume that the Salmonellamediated carcinogenesis is secondary to enhanced epithelial c-Myc expression. However, Salmonella has been shown to induce c-Myc expression [6, 7] and thus might provide both signals. This might also explain why epidemiological studies associate only chronic infection with the emergence of gallbladder cancer, despite the fact that short-term exposure was sufficient to transform c-Myc high epithelial cells [2] . A related question is how the deficiency of the examined Salmonella effector molecules alters the overall bacteria-host cell interaction. The results presented by Scanu and colleagues suggest a major influence on bacterial invasion, intracellular survival, and proliferation, and thus, indirect downstream effects might contribute to the observed phenotype. For example, Salmonella translocates a second set of effector proteins encoded by the so-called Salmonella pathogenicity island (SPI) 2 once it reaches the intracellular vacuole. Individual SPI2 effectors, such as SpiC, have also been shown to stimulate MAPK and might thus contribute to GBC development [8] . Finally, the precise molecular mechanisms that promote carcinogenesis downstream of Akt and MAPK activation remain unclear. Constitutive MAPK signaling has been linked to epigenetic changes involving histone phosphorylation, which might explain the lasting carcinogenic effects of short-term bacterial exposure [9] . Consistently, the epigenetic modulator histone deacetylase 9 (HDAC9) was found to be up-regulated upon bacterial contact. Marked epigenetic differences have been noted between gallbladder tissues from patients from the US and Chile, countries of low and high incidence of S. Typhi infection, respectively [10] . The authors discuss the presence of similar epidemiological associations between cancer and other pathogenic bacteria, such as Chlamydia spp. and Mycobacterium tuberculosis, calling for detailed studies of the possible bacterial contribution to carcinogenesis. In addition, commensal bacteria might exert similar responses and should be examined for their potential to support the development of tumors, particularly within the gastrointestinal tract. Ongoing studies on the composition of the enteric microbiota in patients with malignancies might give a first hint on potential additional bacterial actors in this deadly play. Salmonella pathogenicity island (SPI) 1 effector proteins and/or Salmonella invasion activate MAPK and Akt signaling. This, in turn, drives the expression of genes such as histone deacetylase (HDAC) 9, which are able to induce epigenetic modifications. In the pre-disposed host, such as one expressing enhanced levels of c-Myc, these changes may lead to tumor formation.
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